Condition
Pulmonary Embolism
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 90 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownThrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated ThrombosisNCT06386107 · 2025-09-02
RECRUITINGIdentification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled BreathNCT06528418 · 2024-06-30
RECRUITINGPharmacy-led Transitions of Care Intervention to Improve Medication AdherenceNCT06374277 · 2024-04-06
RECRUITINGClinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICUNCT06538376 · 2023-12-12
RECRUITINGChinese PE Multimodality Imaging Artificial Intelligence StudyNCT06526468 · 2010-09-01
RECRUITINGAugmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PENCT06310018 · 2027-01-01
SUSPENDEDPulmonary Artery Pressure in Predicting Pulmonary Embolism in Patients Presenting To The Emergency Department With DyspneaNCT07641400 · 2026-06-01
NOT_YET_RECRUITINGIntervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer SurgeryNCT06451003 · 2024-07-01
ACTIVE_NOT_RECRUITINGMacitentan to Prevent PRVONCT05946811 · 2024-05-01
WITHDRAWNPredictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung CancerNCT06017271 · 2024-05-01
WITHDRAWNEvaluating the Potential of Large Language Models for Respiratory Disease ConsultationsNCT06457269 · 2023-10-01
COMPLETEDConstruction of Early Warning Model for Pulmonary Complications Risk of Surgical Patients Based on Multimodal Data FusionNCT06057688 · 2023-08-01
UNKNOWNValidation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary EmbolismNCT05568927 · 2022-11-15
COMPLETEDA Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTENCT05171075 · 2022-09-27
TERMINATEDA Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTENCT05171049 · 2022-05-05
TERMINATEDThe Use of a Monitoring Device by General Practitioners During Out-of-hours CareNCT05222711 · 2022-05-01
UNKNOWNVentilation and Perfusion Scan in Pulmonary Embolism Following Catheter Directed Thrombectomy Versus Anticoagulation AloneNCT05133713 · 2022-04-01
UNKNOWNAnalysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 InfectionNCT05226416 · 2022-02-21
COMPLETEDArterial and End-Tidal CO2 Gradient as a Mortality Predictor in Critical Care PatientsNCT05341258 · 2022-01-01
COMPLETEDCHIPs-VTE Study in Hospitalized Patients With Lung CancerNCT04158973 · 2021-12-01
UNKNOWNOn Dose Efficiency of Modern CT-scanners in Chest ScansNCT04996693 · 2021-10-07
COMPLETEDA Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement SurgeryNCT03804125 · 2021-09-01
WITHDRAWNEnoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot StudyNCT03988231 · 2021-07-01
WITHDRAWNFeasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO PatientsNCT04689451 · 2021-02-01
UNKNOWNDeveloping Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung DisordersNCT02748798 · 2020-11-10
TERMINATEDLatest Imaging SPECT System Evaluation Phase 1NCT04704349 · 2020-10-05
COMPLETEDThe Incidence of Pulmonary Embolism During NephrectomyNCT04402749 · 2020-10-01
COMPLETEDAssociations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian FailureNCT04943354 · 2020-09-01
COMPLETEDOutcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and WalesNCT04838106 · 2020-08-01
UNKNOWNPharmacokinetics of Apixaban in Patients Undergoing PancreaticoduodenectomyNCT04191928 · 2020-03-03
COMPLETEDScreening for Cancer in Patients With Unprovoked VTENCT03937583 · 2019-10-23
UNKNOWNEvaluating Right Ventricular (RV) Size and Function Using the Upper Valley RV Algorithm and Novel Imaging ModalitiesNCT03935178 · 2019-08-05
TERMINATEDStandard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary EmbolismNCT03988842 · 2019-07-25
TERMINATEDImproving Safety of Diagnosis and Therapy in the Inpatient SettingNCT04393909 · 2019-07-01
COMPLETEDSafety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With MalignancyNCT04657120 · 2019-06-01
COMPLETEDLow-dose CT Angiography in the Detection of Acute Pulmonary Embolism: Validation in an Obese PopulationNCT04018014 · 2019-03-21
UNKNOWNThe Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort StudyNCT03835780 · 2019-02-01
COMPLETEDPeripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PENCT03581877 · 2019-01-28
ACTIVE_NOT_RECRUITINGPrevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology PatientsNCT03909399 · 2019-01-25
UNKNOWNSymptom-related Screening for Early Detection of CTEPH.NCT03953560 · 2019-01-16
COMPLETEDPrevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH)NCT03719027 · 2018-10-30
COMPLETEDQuantitative Assessment of RV Strain Using cMRI Following Catheter Intervention on PENCT03341208 · 2017-12-01
UNKNOWNData Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT CameraNCT03438123 · 2017-11-28
COMPLETEDA Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous ThromboembolismNCT03240120 · 2017-09-01
UNKNOWNApixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation TherapyNCT03080883 · 2017-07-14
COMPLETEDPREvention of VENous ThromboEmbolism Following Radical ProstatectomyNCT03006562 · 2017-07-01
TERMINATEDA Survey of Hospitalizations in Cardiology Units in Sub-Saharan AfricaNCT03231449 · 2017-02-01
UNKNOWNPulmonary Endarterectomy Guided by CT Scanning for Patients With Chronic Thromboembolic Pulmonary Hypertension----PEACTNCT03795740 · 2017-02-01
UNKNOWNPulmonary Embolism: Mechanism and Therapeutic InnovationNCT05360992 · 2017-01-01
COMPLETEDCTEPH in Patients With Prior Pulmonary Embolism and Risk Score ValidationNCT04681014 · 2016-01-21
UNKNOWNApixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous ThromboembolismNCT02585713 · 2015-11-20
COMPLETEDRivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer CenterNCT02502396 · 2015-09-28
COMPLETEDExtended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic SurgeryNCT02334007 · 2015-09-01
COMPLETEDFree DNA and Nucleosome Concentrations in Pathological PregnanciesNCT01736826 · 2015-06-01
COMPLETEDRegistry Of Acute meDical Emergencies in BrazilNCT02753023 · 2015-05-01
UNKNOWNEvaluation of Lung Doppler Signals in Patients Presenting to EMDNCT01961141 · 2014-11-01
WITHDRAWNPulmonary Embolism as a Cause of COPD ExacerbationsNCT02238639 · 2014-10-01
COMPLETEDLung Ultrasound in Pleuritic Chest PainNCT02107001 · 2014-03-01
COMPLETEDCorrelation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac SurgeryNCT02097602 · 2014-02-01
COMPLETEDExtended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung ResectionNCT02258958 · 2014-01-01
COMPLETEDCommon interventions
ApixabanDRUG6PlaceboDRUG3AbelacimabBIOLOGICAL2AlteplaseDRUG2DalteparinDRUG2EnoxaparinDRUG2No interventionOTHER2TinzaparinDRUG2129Xe Small and Large Human Lung CoilDEVICE13-D CT scanningDIAGNOSTIC_TEST13He Human Lung CoilDEVICE164-MDCT ScanningPROCEDURE1Acetylcysteine InhalationDRUG1Actilyse (Thrombolytic therapy)DRUG1Artificial IntelligenceDEVICE1Bleeding-risk based prophylaxis strategy during hospitalization and extended pharmacological treatment after dischargeOTHER1Blood work, Months 1 & 2BIOLOGICAL1Bloodwork, baselineBIOLOGICAL1Bloodwork, Months -1 to -6BIOLOGICAL1Cardiac Magnetic Resonance ImagingDIAGNOSTIC_TEST1Catheter directed therapyDEVICE1Comprehensive computed tomography of the abdomen/pelvisDEVICE1CT angiographyOTHER1CT pulmonary angio, blood testsOTHER1CT pulmonary angiogram and d-dimer drawPROCEDURE1
Leading sponsors
Brigham and Women's Hospital
7
Ottawa Hospital Research Institute
4
Academic and Community Cancer Research United
2
Anthos Therapeutics, Inc.
2
China-Japan Friendship Hospital
2
Johns Hopkins University
2
McMaster University
2
University of Arizona
2
Abbott RDx Cardiometabolic
1
Antalya Health Sciences University
1
Assistance Publique - Hôpitaux de Paris
1
Bristol-Myers Squibb
1
Cardiologie et Développement
1
Centre Hospitalier Régional d'Orléans
1
Centre Hospitalier Universitaire de Nīmes
1
Trial status mix
COMPLETED47
UNKNOWN19
TERMINATED8
WITHDRAWN6
RECRUITING5
ACTIVE_NOT_RECRUITING3
NOT_YET_RECRUITING1
SUSPENDED1
Phase mix
NA20
PHASE38
PHASE47
PHASE15
PHASE25
EARLY_PHASE12
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.